You just read:

The Medicines Patent Pool (MPP) Broadens Collaboration with Gilead Sciences: Signs Licence for Phase III Medicine Tenofovir Alafenamide (TAF)

News provided by

Medicines Patent Pool (MPP)

24 Jul, 2014, 05:30 BST